Infliximab and Basiliximab for Treatment of Steroid Refractory Acute Graft Versus Host Disease
Sponsor: Nationwide Children's Hospital
Terminated
Sponsor withdrew support
Other terminated trials from Nationwide Children's Hospital
A PHASE2 clinical study on Acute GVH Disease and Graft Versus Host Disease, this trial is terminated or withdrawn. The trial is conducted by Nationwide Children's Hospital and has accumulated 9 data snapshots since 2011. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
9 versions recorded-
Sep 2024 — Present [monthly]
Terminated PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE2
-
Jan 2023 — Jul 2024 [monthly]
Terminated PHASE2
-
Dec 2022 — Jan 2023 [monthly]
Terminated PHASE2
-
Jan 2021 — Dec 2022 [monthly]
Terminated PHASE2
▶ Show 4 earlier versions
-
May 2019 — Jan 2021 [monthly]
Terminated PHASE2
Status: Unknown Status → Terminated
-
Mar 2019 — May 2019 [monthly]
Unknown Status PHASE2
Status: Active Not Recruiting → Unknown Status
-
Jun 2018 — Mar 2019 [monthly]
Active Not Recruiting PHASE2
-
Jan 2017 — Jun 2018 [monthly]
Active Not Recruiting PHASE2
First recorded
Dec 2011
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Nationwide Children's Hospital
For direct contact, visit the study record on ClinicalTrials.gov .